BTX News and Press, Brooklyn ImmunoTherapeutics Inc. From 02/14/19

ALAMEDA, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today provided a business update which included information on AgeX Therapeutics, Inc. (AgeX) (NYSE American: AGE) and BioT...

HENDERSON, NV / ACCESSWIRE / February 5, 2019 / Friday, LD Micro reinstituted their nearly 1000 company index of micro-caps, with the belief that our industry needs a truly accurate indicator of what is going on in the micro-cap world. We took the opportunity to put a microscope on these mi...

Co-Diagnostics (NASDAQ: CODX ) +176%  on eliminating debt . More news on: Co-Diagnostics, Eyenovia, Inc., Ekso Bionics Holdings, Inc., Stocks on the move, , Read more ...

ALAMEDA, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that its affiliate company, OncoCyte Corporation (OncoCyte) (OCX) , a developer of novel, non-invasive tests...